Jutta Zeisler

3.7k citations

45 papers · 2.8k indexed · 1 hit paper · h-index 19

Molecular Biology top 5%
Cellular and Molecular Neuroscience top 1%
Neurology top 2%
Radiology, Nuclear Medicine and Imaging top 5%
Oncology top 10%

Co-authors: Michael R. Hayden Susan E. Andrew Jane Theilmann Jamal Nasir John R. OʼKusky Berry Kremer Håkan Telenius Y. Paul Goldberg
Topics: Radiopharmaceutical Chemistry and Applications (15 papers)Peptidase Inhibition and Analysis (15 papers)Genetic Neurodegenerative Diseases (8 papers)
Cited by: Cellular and Molecular Neuroscience Neurology Molecular Biology
Journals: New England Journal of Medicine Cell Angewandte Chemie International Edition
Partner nations: Canada United States Germany

In The Last Decade

Jutta Zeisler

44 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes

1995 633 citations Jamal Nasir, Jutta Zeisler et al. profile →

Peers

Countries citing papers authored by Jutta Zeisler

Since Specialization

Citations

This map shows the geographic impact of Jutta Zeisler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jutta Zeisler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jutta Zeisler more than expected).

Fields of papers citing papers by Jutta Zeisler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jutta Zeisler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jutta Zeisler. The network helps show where Jutta Zeisler may publish in the future.

Co-authorship network of co-authors of Jutta Zeisler

This figure shows the co-authorship network connecting the top 25 collaborators of Jutta Zeisler. A scholar is included among the top collaborators of Jutta Zeisler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jutta Zeisler. Jutta Zeisler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	5‐Hydroxypyrroloindoline Affords Tryptathionine and 2,2′‐bis‐Indole Peptide Staples: Application to Melanotan‐II 2024 ·Chemistry - A European Journal ·(unknown),Antoine Blanc,(unknown),Jerome Lozada,(unknown),Jutta Zeisler,Chengcheng Zhang,Helen Merkens,François Bénard,David M. Perrin	3
2	Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH 2024 ·Nuclear Medicine and Biology ·(unknown),(unknown),Chengcheng Zhang,(unknown),Michiel Van de Voorde,Jutta Zeisler,(unknown),Sathiya Sekar,Zheliang Yuan,Paul Schaffer,Valery Radchenko,Maarten Ooms,P. Kunz,François Bénard,Hua Yang	4
3	Synthesis and Preclinical Evaluation of Three Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging 2023 ·Molecules ·(unknown),Zhengxing Zhang,Hsiou‐Ting Kuo,Helen Merkens,Jutta Zeisler,Ryan Wilson,(unknown),(unknown),François Bénard,Kuo‐Shyan Lin	29
4	Novel 68Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast 2023 ·Pharmaceuticals ·(unknown),Hsiou‐Ting Kuo,Helen Merkens,Jutta Zeisler,(unknown),(unknown),François Bénard,Kuo‐Shyan Lin	7
5	68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake 2023 ·Molecules ·Lei Wang,(unknown),Zhengxing Zhang,Hsiou‐Ting Kuo,Helen Merkens,Jutta Zeisler,Chengcheng Zhang,(unknown),François Bénard,Kuo‐Shyan Lin	6
6	Synthesis and Evaluation of 68Ga-Labeled (2S,4S)-4-Fluoropyrrolidine-2-Carbonitrile and (4R)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging 2023 ·Molecules ·(unknown),Zhengxing Zhang,Nadine Colpo,Jutta Zeisler,(unknown),François Bénard,Kuo‐Shyan Lin	4
7	Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands 2022 ·Clinical Cancer Research ·Daniel Kwon,Katsuyoshi Takata,Zhengxing Zhang,Lauren C. Chong,(unknown),Jutta Zeisler,Tomoko Miyata‐Takata,Helen Merkens,Julie Rousseau,Tomohiro Aoki,Hsiou‐Ting Kuo,(unknown),Chengcheng Zhang,Joseph Lau,Diego Villa,Carlos Uribe,Kuo‐Shyan Lin,Christian Steidl,François Bénard	8
8	H₄picoopa─Robust Chelate for ²²⁵Ac/¹¹¹In Theranostics 2022 ·Bioconjugate Chemistry ·(unknown),Marı́a de Guadalupe Jaraquemada-Peláez,Chengcheng Zhang,Jutta Zeisler,Cristina Rodríguez‐Rodríguez,(unknown),Valery Radchenko,Hua Yang,Kuo‐Shyan Lin,François Bénard,Paul Schaffer,Chris Orvig	13
9	68Ga-Labeled [Leu13ψThz14]Bombesin(7–14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake 2022 ·Molecules ·Lei Wang,Zhengxing Zhang,Helen Merkens,Jutta Zeisler,Chengcheng Zhang,Áron Roxin,(unknown),François Bénard,Kuo‐Shyan Lin	12
10	Synthesis of DOTA-pyridine chelates for 64Cu coordination and radiolabeling of αMSH peptide 2021 ·EJNMMI Radiopharmacy and Chemistry ·Hua Yang,Feng Gao,(unknown),Chengcheng Zhang,Zheliang Yuan,Stefan Zeisler,(unknown),Jutta Zeisler,François Bénard,Caterina F. Ramogida,Paul Schaffer	13
11	Comparison of biological properties of [¹⁷⁷Lu]Lu‐ProBOMB1 and [¹⁷⁷Lu]Lu‐NeoBOMB1 for GRPR targeting 2019 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Étienne Rousseau,Joseph Lau,Zhengxing Zhang,Chengcheng Zhang,Daniel Kwon,Carlos Uribe,Hsiou‐Ting Kuo,Jutta Zeisler,(unknown),Kuo‐Shyan Lin,François Bénard	11
12	Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE 2018 ·Nuclear Medicine and Biology ·Étienne Rousseau,Joseph Lau,Zhengxing Zhang,Carlos Uribe,Hsiou‐Ting Kuo,Chengcheng Zhang,Jutta Zeisler,Nadine Colpo,Kuo‐Shyan Lin,François Bénard	32
13	Design, synthesis and evaluation of 18F-labeled bradykinin B1 receptor-targeting small molecules for PET imaging 2016 ·Bioorganic & Medicinal Chemistry Letters ·Zhengxing Zhang,Hsiou‐Ting Kuo,Joseph Lau,Silvia Jenni,Chengcheng Zhang,Jutta Zeisler,François Bénard,Kuo‐Shyan Lin	6
14	Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel–Chelator Complex on Biodistribution and Tumor Uptake 2016 ·Molecular Pharmaceutics ·Zhengxing Zhang,(unknown),Jinhe Pan,Silvia Jenni,Jutta Zeisler,Chengcheng Zhang,Zhibo Liu,David M. Perrin,François Bénard,Kuo‐Shyan Lin	13
15	Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas 1998 ·The Journal of Pathology ·Jutta Herbers,(unknown),Jerzy Chudek,Peter Bugert,Hiroshi Kanamaru,Jutta Zeisler,Börje Ljungberg,Mohammed Akhtar,Gyula Kovács	28
16	Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour 1997 ·The Journal of Pathology ·(unknown),Maimoona A. Zariwala,Peter Bugert,Jutta Zeisler,(unknown)	39
17	Structural analysis of the 5′ region of mouse and human huntington disease genes reveals conservation of putative promoter region and di- and trinucleotide polymorphisms 1995 ·Genomics ·Biaoyang Lin,Jamal Nasir,Michael A. Kalchman,Helen McDonald,Jutta Zeisler,Y. Paul Goldberg,Michael R. Hayden	33
18	A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing 1994 ·Human Molecular Genetics ·Susan E. Andrew,Y. Paul Goldberg,Jane Theilmann,Jutta Zeisler,Michael R. Hayden	127
19	A Worldwide Study of the Huntington's Disease Mutation: The Sensitivity and Specificity of Measuring CAG Repeats 1994 ·New England Journal of Medicine ·Berry Kremer,Paul Goldberg,Susan E. Andrew,Jane Theilmann,Håkan Telenius,Jutta Zeisler,Ferdinando Squitieri,Biaoyang Lin,(unknown),(unknown),Thomas D. Bird,Michael R. Hayden	428
20	Geographical distribution of haplotypes in Swedish families with Huntington's disease 1994 ·Human Genetics ·E. Almqvist,Susan E. Andrew,Jane Theilmann,Paul Goldberg,Jutta Zeisler,Ulf Drugge,Ulla Grandell,(unknown),Bengt Winblad,Michael R. Hayden,Maria Anvret	8

About Jutta Zeisler

Jutta Zeisler is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Cellular and Molecular Neuroscience, having authored 45 papers that have together received 2.8k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (15 papers), Peptidase Inhibition and Analysis (15 papers) and Genetic Neurodegenerative Diseases (8 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.6k citations), Neurology (677 citations) and Molecular Biology (2.0k citations). Jutta Zeisler has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Michael R. Hayden, Susan E. Andrew, Jane Theilmann, Jamal Nasir, John R. OʼKusky, Berry Kremer, Håkan Telenius, Y. Paul Goldberg, Joy M. Richman and Jamey D. Marth. Their work appears in journals such as New England Journal of Medicine, Cell and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact